Veldoreotide

DB12777InvestigationalProtein Based Therapies

Somatoprim is under investigation for the treatment of Acromegaly.

Mechanism: Pharmacologically active on Somatostatin receptor type 5, Somatostatin receptor type 2, and Somatostatin receptor type 4
Curator reviewed
Code names: DG-3173 · PTR-3173

Resolves to

Compound

Targets

What you can answer from here — as of September 12, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Veldoreotide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.